Monte Rosa Therapeutics (GLUE) Share-based Compensation (2020 - 2026)
Monte Rosa Therapeutics (GLUE) posted Share-based Compensation of $5.97 million for Q2 2026, up 22.0% from $4.89 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Share-based Compensation (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Monte Rosa Therapeutics was $20.59 million, up 8.7% year-over-year; for FY2025, it came in at $18.87 million, up 4.1% from FY2024.
- Annual Share-based Compensation has increased for four consecutive years, with a five-year compound annual growth rate of 121.5% (FY2020 to FY2025).
- In prior years, Monte Rosa Therapeutics' Share-based Compensation was $18.13 million in FY2024 (+8.7%), $16.67 million in FY2023 (+42.9%), $11.66 million in FY2022 (+124.3%) and $5.2 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Share-based Compensation in data going back to Q3 2020.
- On a year-over-year basis, Share-based Compensation increased in six of the last eight quarters, with growth averaging 6.9%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2021, with growth of 823.4%; the weakest was Q3 2024, with a decline of 4.2%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $5.95 million (Q1 2026), $4.31 million (Q4 2025) and $4.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Monte Rosa Therapeutics | 998.00 Mn | 409.81 Mn | - | 5.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.97 Mn |
| Mar 31, 2026 | 5.95 Mn |
| Dec 31, 2025 | 4.31 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Jun 30, 2025 | 4.89 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Dec 31, 2024 | 4.47 Mn |
| Sep 30, 2024 | 4.28 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Mar 31, 2024 | 4.87 Mn |
| Dec 31, 2023 | 4.07 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 4.15 Mn |
| Mar 31, 2023 | 3.97 Mn |
| Dec 31, 2022 | 3.33 Mn |
| Sep 30, 2022 | 3.21 Mn |
| Jun 30, 2022 | 2.87 Mn |
| Mar 31, 2022 | 2.25 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 2.07 Mn |
API Access
Monte Rosa Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GLUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();